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An antimicrobial protein from seeds of Pharbitis nil (Pn-AMP) which
shows an antifungal activity towards several agriculturally important
plant pathogens has been crystallized in the presence of equimolar
N-acetylglucosamine with sodium citrate as precipitant. The crystal
belongs to the hexagonal space group P6122 (or P6522), with unit-cell
parameters a = b = 29.33 (5), c = 133.44 (12) AÊ . Native data were
collected using a crystal at 100 K to a resolution of 1.78 AÊ .
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1. Introduction
In order to protect themselves from pathogenic
invasion, plants produce many antimicrobial
proteins such as chitinases, -1,3-glucanases,
ribosome-inactivating proteins and cysteine/
glycine-rich small antimicrobial proteins
(Stintzi et al., 1993). One of the small anti-
microbial proteins, hevein, is a small cysteine-
rich chitin-binding protein from the rubber
tree (Hevea brasiliensis). The 43-residue
sequence of hevein, known as the hevein
domain, contains eight cysteine residues
that are all involved in disul®de bridges
with a unique topological arrangement
(CX8CX4CCX5CX6CX3CX3C; Fig. 1). This
domain has so far been found in a wide array
of unrelated fungal and plant proteins. Aside
from hevein and hevein-like proteins which
consist of single copy of the domain itself, the
chitin-binding proteins such as wheat-germ
agglutinin and plant endochitinases are
composed of multiple repeated hevein
domains. Interestingly, yeast killer toxin and
Kluyveromyces lactis killer toxin also contain a
hevein domain in the central section of the
protein (Fig. 1). Although the hevein domain is
found in many plant proteins, it is not known
how hevein and hevein-like proteins exhibit
antifungal and/or antibacterial activities at the
molecular level. It has been suggested that the
mode of action of chitin-binding lectins
involves the proteins penetrating into the cell
and affecting the cell-wall synthesis of fungi
that contain chitin. Cell penetration by the
hevein domain has also been proposed from
the fact that the hevein domain-containing
class I chitinases show signi®cantly stronger
in vitro antifungal activity than the class II
chitinases lacking the domain (Iseli et al.,
1993). From these observations, it is believed
that the capability for chitin binding may play
an important role in the antifungal activities of
hevein and hevein-like proteins.
Structural studies of hevein (Rodriguez-
Romero et al., 1991; Asensio et al., 1998), of
wheat-germ agglutinin (Wright, 1987) and of
Urtica dioica agglutinin (Harata & Muraki,
2000; Saul et al., 2000) revealed that hevein
domains have identical disul®de-bridge pairing
as well as similar tertiary structures. Anti-
microbial protein from Amaranthus caudatus,
which contains only three cystines, also has a
similar fold to that of hevein (Martins et al.,
Figure 1
Comparison of the amino-acid sequence of Pn-AMP1 with other hevein-like proteins and yeast killer toxin. The
sequences aligned are from rubber latex hevein (Hevein), antimicrobial peptide from A. caudatus (Ac-AMP2), barley
chitinase (Barley CHI), tobacco antifungal protein (CBP20), U. dioica agglutinin (UDA), wheatgerm agglutinin 3
isolectin (WGA3), pollen allergen RA5 from Ambrosia elatior (Allegen R), antimicrobial peptide from elderberry fruit
(Sn-HLPf) and K. lactis killer toxin -subunit (Killer Toxin). The numbers on the right indicate the ®rst and last amino
acids used in the alignment.
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1996). However, current structural data
cannot give any further clues to under-
standing the antifungal activity of hevein-
like proteins. In addition, a high-resolution
structure is essential to clarify the protein±
chitin interaction which is presumed to be
important for antifungal activity.
Two antimicrobial proteins (Pn-AMP1
and Pn-AMP2) were isolated from morning
glory seeds (P. nil; Koo et al., 1998). The
amino-acid sequences of Pn-AMP1 and Pn-
AMP2 are identical except that Pn-AMP1
has an additional serine residue at the
carboxyl-terminus. Pn-AMP1 has 77%
sequence identity to hevein and showed
potent antifungal activity against a broad
spectrum of fungi, including fungi that do
not contain chitin in their cell walls (Koo et
al., 1998). Since it is known that Pn-AMPs
shows a similar fungicidal effect to thionin
by disrupting the fungal membrane and
causing the leakage of cytoplasmic materials,
they might have a different mode of anti-
microbial action to hevein (Koo et al., 1998).
To elucidate a molecular mechanism for
chitin binding and antifungal properties of
Pn-AMP that would differ from that of
hevein, high-resolution structural study is
necessary. In addition, structural study of
Pn-AMP could elucidate the implications of
sequence conservation among yeast killer
toxin and hevein-like proteins. As a ®rst step
in structural study, Pn-AMP1 has been
crystallized in the presence of N-acetyl
glucosamine and its preliminary crystallo-
graphic data have been analyzed.
2. Purification and crystallization
Pn-AMP was puri®ed from morning glory
seeds as described by Koo et al. (1998) with
minor modi®cations. A crude extract
prepared by ammonium sulfate precipita-
tion and heat treatment (Koo et al., 1998)
was applied onto a CM-Sepharose (Phar-
macia) column equilibrated with 10 mM
sodium phosphate buffer pH 6.0 and was
eluted with 500 mM NaCl. Fractions
containing antifungal activity were pooled
and applied to a reverse-phase column (C18
silica, SEP-PAK, Waters, Milford, MA,
USA) and eluted with 50% acetonitrile in
0.1% tri¯uoroacetic acid (TFA). The eluted
protein fractions were lyophilized and
dissolved in 400 ml of sterile water and
subjected to reverse-phase HPLC on a
Zorbax C18 column (4.6 150 mm, Hewlett
Packard). The protein peak containing
Pn-AMP1 was eluted with a linear gradient
of 0±70% acetonitrile and dried in a vacuum
concentrator. Pn-AMP1 was dissolved in
water at a concentration of 25 mg mlÿ1 for
crystallization purposes. Initial crystal-
lization conditions were tested using the
Hampton Research Crystal Screens I and II
using the hanging-drop vapour-diffusion
method. 1 ml of protein solution was mixed
with an equal volume of reservoir solution
and equilibrated against 500 ml of reservoir
solution at 295 and 277 K. The same crys-
tallization experiments were performed
using the protein solution
containing N-acetylglucos-
amine, the monomer unit of
chitin, in a 1:1 molar ratio.
Hexagonal rod-shaped crystals
were obtained with 0.64 M
sodium citrate pH 6.2 as preci-
pitant and equimolar N-acet-
ylglucosamine in the protein
drop at 277 K. Crystals grew to
dimensions of 0.2  0.2 
0.5 mm within a month (Fig. 2).
Since crystals were only
obtained in the presence of N-
acetylglucosamine, it can be
assumed that N-acetylglucos-
amine is essential for the crys-
tallization of Pn-AMP.
3. Data collection and processing
Cryocooling was required for collection of
the complete data set owing to the radiation
sensitivity of the crystals. Individual crystals
soaked in a reservoir solution containing
30% glycerol were scooped up in a cryo-loop
and frozen in a nitrogen stream at 100 K.
The ®rst set of X-ray data was collected to
3.0 AÊ from a frozen crystal of Pn-AMP1 on a
MacScience 2030b area detector with
mirror-focused Cu K X-rays ( = 1.5418 AÊ )
from a MacScience M18XHF rotating-anode
generator operated at 50 kVand 90 mA. The
merged data set consists of 769 unique
re¯ections with an Rmerge of 15.5% and 90%
completeness. X-ray diffraction data were
processed and scaled using DENZO and
SCALEPACK from the HKL program suite
(Otwinowski & Minor, 1997). The crystal
belongs to the hexagonal space group P6122
or P6522, with unit-cell parameters
a = b = 29.33 (5), c = 133.44 (12) AÊ .
Assuming a molecular weight of 4300 Da
and one molecule in the asymmetric unit,
the value of the crystal packing parameter
(VM) is 1.93 AÊ
3 Daÿ1 and the solvent
content is 39% (Matthews, 1968).
To obtain a higher resolution crystal
structure for de®ning the interaction
between Pn-AMP1 and N-acetyl-
glucosamine, a second data set was collected
using a Weisenberg camera for macro-
molecular crystallography at the BL-6A
experimental station of the Photon Factory,
Tsukuba, Japan (Sakabe, 1991). To maxi-
mize the anomalous contribution of the S
atoms to phasing, the wavelength for the
data collection was selected to be 1.800 AÊ ;
i.e. the lowest energy available at the
beamline. The diffraction patterns recorded
on image plates (200  400 mm, Fuji
BASIII) were digitized by the off-line
scanner BA100. The oscillation range per
image plate was 5.5, with an overlap of 0.5.
For measuring redundant and reliable
Table 1
Synchrotron data-collection statistics.
Values in parentheses refer to the highest resolution bin.
Space group P6122 or P6522
Unit-cell parameters (AÊ ,) a = b = 29.33 (5),
c = 133.44 (12),
 =  = 90,  = 120
Resolution (AÊ ) 50.0±1.78 (1.84±1.78)
No. of unique re¯ections 3577 (293)
Redundancy 7.38 (3.10)
Rmerge² (%) 7.8 (16.5)
Rano³ (%) 5.3 (11.8)
Completeness (%) 93.9 (79.2)
I/(I) 32.9 (7.9)
Temperature (K) 100
² Rmerge =
P
|I ÿ hIi|/PI. ³ Rano = |F(+) ÿ F(ÿ)|/hFi.
Figure 3
Anomalous Patterson map on Harker section (UV0) in hexagonal
space group P6122 or P6522. The Patterson map was calculated
using data in the 3.0±1.78 AÊ resolution shell and was contoured at
increments of 0.5 from 3.
Figure 2
Hexagonal crystal of Pn-AMP1 grown in the
presence of equimolar N-acetylglucosamine from
citrate solution as the precipitant at 277 K. The
approximate dimensions of the crystal are 0.2 0.2
0.5 mm.
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anomalous signals from eight S atoms in
Pn-AMP1, a full sphere was covered from a
frozen crystal using a crystal-to-detector
distance of 286.5 mm and a 0.1 mm colli-
mator. X-ray diffraction data were
processed and scaled using DENZO and
SCALEPACK (Otwinowski & Minor,
1997). The synchrotron data were collected
from 50.0 to 1.78 AÊ with an Rmerge of 7.8%
and an Rano of 5.3%. Data statistics are
summarized in Table 1.
4. Anomalous Patterson map
Since eight out of 41 residues are cysteine in
Pn-AMP1, the anomalous signal from the S
atoms could be useful for improving the
phase and identifying the four cystines in
the model. Single-wavelength anomalous
diffraction data were collected at 1.800 AÊ ,
where the anomalous scattering coef®cient
f 00 is 0.75 e. When re¯ection data in the
3.0±1.78 AÊ resolution shell were used for
calculation, four anomalous Patterson peaks
that might correspond to the four cystine
residues were identi®ed in the Harker
section w = 0 with peak intensities of 4.84,
3.78, 3.64 and 3.18 (Fig. 3). Further studies
will be undertaken in order to ®nd further
Patterson peaks necessary to identify the
cystine positions.
The crystal structure determination of the
Pn-AMP1 by molecular replacement
combined with anomalous dispersion will
elucidate the atomic details of chitin binding
and the possible antifungal activity of
Pn-AMP.
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